The pharmaceutical and device industries increasingly find themselves the subject of intense government scrutiny. Arent Fox helps these companies to navigate the rough waters by providing fraud and abuse risk assessments related to the sales and marketing of prescription drugs and devices, as well as compliance program development, monitoring, auditing, and training tailored for the drug and device arena. We also track state law developments relating to price reporting, reporting of advertising and marketing costs, registering of clinical trials and reporting of trial results, limitations on prescription data-mining and licensing or other oversight of field sales representations.